EPIRUS BIOPHARMACEUTICALS
EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALEâ„¢ disposable manufacturing system, and designed to be deployed in an "In Market, For Market" â„¢ manufacturing configuration.
EPIRUS BIOPHARMACEUTICALS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2000-03-28
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.epirusbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
6176073437
Email Addresses:
[email protected]
Total Funding:
83.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Font Awesome Domain Not Resolving Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Google Maps
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2015-09-09 | Bioceros | Bioceros acquired by Epirus Biopharmaceuticals | 14.1 M USD |
2014-07-15 | Zalicus | Zalicus acquired by Epirus Biopharmaceuticals | N/A |
Investors List
Livzon Mabpharm
Livzon Mabpharm investment in Series B - Epirus Biopharmaceuticals
TPG Biotech
TPG Biotech investment in Series B - Epirus Biopharmaceuticals
5AM Ventures
5AM Ventures investment in Series B - Epirus Biopharmaceuticals
Mousse Partners
Mousse Partners investment in Series B - Epirus Biopharmaceuticals
Greenwoods Investment
Greenwoods Investment investment in Series B - Epirus Biopharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Series B - Epirus Biopharmaceuticals
Gibralt Capital Corporation
Gibralt Capital Corporation investment in Series B - Epirus Biopharmaceuticals
Adage Capital Management
Adage Capital Management investment in Series B - Epirus Biopharmaceuticals
5AM Ventures
5AM Ventures investment in Venture Round - Epirus Biopharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Venture Round - Epirus Biopharmaceuticals
Official Site Inspections
http://www.epirusbiopharma.com
- Host name: 162.243.32.126
- IP address: 162.243.32.126
- Location: New York United States
- Latitude: 40.7308
- Longitude: -73.9975
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10011